As per MRFR analysis, the China Kidney Stones Market Size was estimated at 156 (USD Million) in 2023.The China Kidney Stones Market Industry is expected to grow from 162(USD Million) in 2024 to 972 (USD Million) by 2035. The China Kidney Stones Market CAGR (growth rate) is expected to be around 17.69% during the forecast period (2025 - 2035).
An increase in the prevalence of kidney stones alongside rising attention from the health care sector and patients is one of the key trends in China Kidney Stones Market. Some of the urban lifestyle factors driving this issue include dietary changes, sedentary lifestyles, and high salt intake. Concerned with the issue, the Chinese government has launched public health campaigns aimed at raising awareness around kidney stones, which in turn has motivated patients to seek timely medical attention and enhanced their access to treatment solutions.
This, along with the continuously expanding treatment options, is positively influencing the market. Other important market factors include the growing adoption of ureteroscopy, shock wave lithotripsy, and advances in minimally invasive surgical techniques.
The change towards less invasive treatment options is associated with improving patient outcomes and lessening recovery time, which is beneficial for both patients and healthcare providers. In addition to these benefits, there is increasing advancement in the creation of new dietary supplements and medications for the prevention and management of kidney stones. Opportunities in the China Kidney Stones Market are expanding in digital health and telemedicine. With the rapid growth in technology, remote consultations and data analysis is easier than ever, resulting in enhanced patient care and management.
Moreover, this younger population suffering from kidney stones could be educated on prevention and lifestyle changes aimed at reducing stone formation.
There is an incorporation of Traditional Chinese Medicine (TCM) in the management of kidney stones by the addition of herbal medicines into the treatment regimen. This culturally centered integrated approach is gaining popularity because it is more acceptable to many patients in China. The combination of health concerns and new methods of treatment and prevention keeps the market alive and active.
The incidence of kidney stones in China has been rising significantly over the last two decades. Recent studies indicate that approximately 10% of the population is affected by kidney stones, and this number continues to grow due to changing dietary habits and lifestyle factors. The Chinese National Health Commission has highlighted this alarming trend, prompting public health initiatives aimed at prevention and treatment. This growing prevalence is expected to drive the China Kidney Stones Market Industry as more patients seek medical intervention and treatments.
Furthermore, major healthcare organizations, such as the Chinese Urological Association, are focusing on increasing awareness and providing educational resources to manage kidney stone prevention, thereby expanding the market for related products and services.
The continuous advancement in treatment technologies for kidney stones is a significant driver for the China Kidney Stones Market Industry. Innovations such as minimally invasive surgical techniques and the development of advanced lithotripsy equipment have drastically improved patient outcomes and recovery times. According to a report from the Ministry of Health of China, the use of such technologies has increased by over 30% in the last five years, correlating with improved patient satisfaction and reduced hospital stays.
Leading manufacturers are investing in Research and Development to enhance these technologies and provide safer, more efficient treatment options, further stimulating market growth.
Public awareness campaigns focused on kidney health are becoming increasingly prevalent in China, contributing to heightened awareness of kidney stones. Organizations such as the Chinese Kidney Foundation have launched initiatives to educate the population about the importance of hydration, dietary choices, and lifestyle modifications to prevent the formation of kidney stones. This awareness is leading to earlier diagnosis and treatment, which is vital for improving health outcomes and driving demand in the China Kidney Stones Market Industry.
Reports indicate that such educational initiatives have led to a 20% increase in public consultations related to kidney health over the past three years.
The China Kidney Stones Market exhibits a diverse range of types that significantly impact its overall dynamics and present varied opportunities for growth. Within the market, Calcium Oxalate Stones stand out as the most prevalent, often attributed to dietary habits and lifestyle choices prevalent in the Chinese population, such as increased consumption of oxalate-rich foods. Their high occurrence prompts a increasing demand for effective treatment options and preventive measures, constituting a major focus for both healthcare providers and patients. Uric Acid stones, another prominent type, have been observed to correlate with rising metabolic disorders and changing dietary patterns, particularly as more individuals adopt high-purine diets which typically stress renal health.
This segment presents unique challenges and opportunities as management strategies evolve to address the underlying causes of these stones. Struvite Kidney Stones, primarily linked to urinary tract infections, showcase another critical angle in the market; their formation and subsequent treatment emphasize the need for comprehensive diagnostic and therapeutic approaches within the healthcare system in China. With a growing awareness around the prevention of infections, the demand for innovative urinary health solutions has grown substantially.
Cystine stones, while less common, pose distinct management challenges due to their genetic link and require specialized attention, highlighting the need for tailored treatment plans. Similarly, Calcium Phosphate Stones, often associated with metabolic and parathyroid disorders, draw attention to underlying health issues which necessitate an integrative healthcare approach for effective management.
As the market continues to evolve, factors such as increased healthcare expenditure and enhanced access to medical technologies are expected to spur growth within each type segment. Furthermore, the growing emphasis on health awareness is expected to push for more preventive care related to the factors leading to kidney stone formation. The expansion of the China Kidney Stones Market is set against a backdrop of demographic changes, lifestyle adaptations, and a deeper understanding of nutrition's role in kidney health.
Each of these types not only contributes to a comprehensive understanding of medicine but also highlights significant opportunities for advancements in treatment and prevention strategies that cater specifically to the unique challenges posed by kidney stones within the Chinese context.
The Treatment Type segment of the China Kidney Stones Market is characterized by a diverse range of methods aimed at addressing kidney stones effectively. Medications play a crucial role, as they often serve as the first line of defense against stone formation and related discomfort, making them significant in patient management. Extracorporeal Shock Wave Lithotripsy is notable for its non-invasive nature, utilizing shock waves to disintegrate stones without the need for surgical intervention, which appeals to a growing number of patients favoring less invasive options.
Ureteroscopy, on the other hand, involves the direct removal of stones using a ureteroscope, offering a more immediate solution for larger stones and a high success rate, thus establishing its importance in the treatment landscape. Percutaneous Nephrolithotomy, while more invasive, is crucial for treating complex cases and larger stones, showcasing advancements in surgical techniques and technology within the sector.
The rising prevalence of kidney stones in China, influenced by factors such as dietary habits, increased dehydration rates, and sedentary lifestyles, is expected to drive growth across all treatment modalities, underscoring the segment's critical role in the overall kidney stones management framework.
The Diagnosis segment of the China Kidney Stones Market is a critical aspect as it plays a vital role in determining appropriate treatment and management strategies for patients diagnosed with kidney stones. Various diagnostic methods such as Ultrasound, Intravenous Pyelography, CT scans, X-Rays, and other techniques contribute to a comprehensive approach in identifying kidney stones. Ultrasound remains a widely accessible and non-invasive option, making it popular in initial screenings. Intravenous Pyelography is efficient for assessing renal function and the urinary tract, while CT scans are often favored for their high accuracy in detecting stone sizes and locations, thereby aiding surgical decisions.
X-Rays, although less commonly used today, still hold importance in specific scenarios due to their rapid availability. The demand for innovative diagnostic techniques is driven by the increasing prevalence of kidney stones within the growing population of China, alongside advancing health care technologies. As hospitals and diagnostic centers expand their offerings, the integration of these diagnostic tools not only enhances patient outcomes but also shapes the overall landscape of the China Kidney Stones Market, reflecting the trends towards increased efficiency and precision in patient care.
The China Kidney Stones Market is characterized by a rapidly evolving landscape driven by increasing prevalence of kidney stone diseases, advancements in diagnostic technologies, and a growing demand for effective treatment options. Competitive insights indicate a significant focus on research and development, as companies work to innovate new imaging techniques and minimally invasive surgical procedures tailored especially for the unique health challenges presented in the Chinese population.
This dynamic market environment highlights the interplay between established players and new entrants who are striving to capture market share through product differentiation and strategic collaborations. As healthcare reforms progress and patient awareness improves, the market is poised for substantial growth, underscoring the importance of understanding competitive positioning and market trends.
Siemens Healthineers has established a strong footprint in the China Kidney Stones Market by leveraging its extensive portfolio of advanced imaging solutions and diagnostic tools that cater to nephrological healthcare needs. The company's commitment to innovation has positioned it favorably, with a range of state-of-the-art technologies that facilitate the early detection and accurate diagnosis of kidney stones. Siemens Healthineers excels in providing comprehensive solutions that integrate imaging and treatment options, enhancing patient outcomes and operational efficiency for healthcare providers. Its ability to foster partnerships within the Chinese healthcare ecosystem and actively participate in local medical conferences underscores its strategic approach to strengthening its market presence and maintaining a competitive edge.
Philips Healthcare is another prominent player in the China Kidney Stones Market, recognized for its commitment to delivering high-quality medical imaging products and patient-centric solutions. The company's key offerings include advanced imaging modalities such as ultrasound and computed tomography, which play a crucial role in the diagnosis and management of kidney stones. Philips Healthcare has made significant strides in enhancing its market presence through strategic mergers and acquisitions, enabling it to expand its capabilities and access valuable resources in the region.
The company’s strengths lie in its innovative technologies and holistic approach to patient care, which are tailored to meet the specific needs of the Chinese population. Philips continues to invest in research and development to optimize its products and services, ensuring that it remains competitive in the evolving landscape of the China Kidney Stones Market.
China Kidney Stones Market Industry Developments
Recent developments in the China Kidney Stones Market highlight significant advancements and ongoing trends in the healthcare sector. In September 2023, Siemens Healthineers announced the launch of new imaging technologies aimed at enhancing diagnosis and treatment of renal calculi, ensuring improved patient outcomes. Concurrently, Philips Healthcare introduced advanced lithotripsy systems in the market, reflecting a strong focus on innovation. In terms of growth, the market valuation for companies involved, such as Stryker Corporation and Cook Medical, has seen steady progress due to an increasing prevalence of kidney stones in the region, driven in part by dietary shifts and lifestyle changes.
The competitive landscape has also witnessed consolidation, with GE Healthcare acquiring a minority stake in Shanghai United Imaging Healthcare in August 2023, aiming to combine resources and enhance research capabilities. This acquisition is set to foster collaboration in the development of cutting-edge solutions for kidney stone management. Overall, the market is evolving rapidly, with industry players notably investing in Research and Development and addressing the rising demand for efficient treatments among the Chinese population.
| Report Attribute/Metric Source: | Details |
| MARKET SIZE 2018 | 156.0(USD Million) |
| MARKET SIZE 2024 | 162.0(USD Million) |
| MARKET SIZE 2035 | 972.0(USD Million) |
| COMPOUND ANNUAL GROWTH RATE (CAGR) | 17.69% (2025 - 2035) |
| REPORT COVERAGE | Revenue Forecast, Competitive Landscape, Growth Factors, and Trends |
| BASE YEAR | 2024 |
| MARKET FORECAST PERIOD | 2025 - 2035 |
| HISTORICAL DATA | 2019 - 2024 |
| MARKET FORECAST UNITS | USD Million |
| KEY COMPANIES PROFILED | Siemens Healthineers, Philips Healthcare, Tianjin Zhongyun Medical Instruments, Stryker Corporation, Cook Medical, Boston Scientific, Nanfang Zhongjin Medical, Shandong Xinhua Pharmaceutical, Hitachi Medical Systems, Medtronic, UroGen Pharma, Zebra Medical Vision, Fujifilm Holdings, GE Healthcare, Shanghai United Imaging Healthcare |
| SEGMENTS COVERED | Type, Treatment Type, Diagnosis |
| KEY MARKET OPPORTUNITIES | Rising prevalence of kidney stones, Increasing healthcare expenditure, Growing demand for minimally invasive procedures, Advancements in treatment technologies, Expanding patient awareness and education |
| KEY MARKET DYNAMICS | rising diabetes prevalence, increasing sedentary lifestyle, growing awareness of treatment, advancements in medical technology, expanding healthcare infrastructure |
| COUNTRIES COVERED | China |
Frequently Asked Questions (FAQ) :
The China Kidney Stones Market is expected to be valued at 162.0 USD Million in 2024.
By 2035, the China Kidney Stones Market is projected to reach a value of 972.0 USD Million.
The China Kidney Stones Market is expected to experience a CAGR of 17.69% during the period from 2025 to 2035.
In 2024, Calcium Oxalate Stones are expected to hold the largest market share, valued at 48.6 USD Million.
The market for Uric Acid kidney stones is expected to grow from 32.4 USD Million in 2024 to 194.4 USD Million by 2035.
Key players in the China Kidney Stones Market include Siemens Healthineers, Philips Healthcare, and Medtronic among others.
The market size for Struvite Kidney Stones is anticipated to be 30.0 USD Million in 2024.
The market size for Cystine Stones is expected to grow from 23.0 USD Million in 2024 to 138.0 USD Million by 2035.
Emerging trends in the China Kidney Stones Market include advancements in medical technology and increased awareness about kidney health.
By 2035, the segment for Calcium Oxalate Stones is projected to have the highest market value at 291.6 USD Million.
Leading companies partner with us for data-driven Insights.
Kindly complete the form below to receive a free sample of this Report
Analyst Explore the profile of garvit vyas, one of our esteemed authors at market research future, and access their expert research contributions in the field of market research and industry analysis
Get in Touch
© 2025 Market Research Future ® (Part of WantStats Reasearch And Media Pvt. Ltd.)
